Astrazeneca Plc (AZN)

Historical Portfolio Holders from 2014 to 2024

All holders as of
Q1 2024
Type / Class
Equity / SPONSORED ADR
Shares, Excl. Options Q1 2024
$471 M
Holdings value Q1 2024
$31.9 B
Value change Q1 2024
+$143 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
1174
Number of Buys Q1 2024
562
Number of Sells Q1 2024
-414
Average Buys Q1 2024 %
+0.007%
Average Sells Q1 2024 %
-0.005%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Filings
Period Shares, Excl. Options Value, Excl. Options Change Price Filings
2024 Q1 471 M $31.9 B +$143 M $67.75 1,121
2023 Q4 474 M $31.9 B -$111 M $67.35 1,120
2023 Q3 488 M $33 B +$284 M $67.72 1,077
2023 Q2 486 M $34.8 B -$599 M $71.57 1,103
2023 Q1 499 M $34.4 B -$1.36 M $69.41 1,064
2022 Q4 508 M $34.9 B -$77.7 M $67.80 1,079
2022 Q3 513 M $28.1 B -$194 M $54.84 984
2022 Q2 526 M $34.8 B +$1.34 B $66.07 1,028
2022 Q1 514 M $34.1 B +$976 M $66.34 994
2021 Q4 501 M $29.2 B -$345 M $58.25 973
2021 Q3 514 M $30.9 B +$5.13 B $60.06 944
2021 Q2 434 M $26 B +$1.95 B $59.90 802
2021 Q1 411 M $20.5 B +$1.29 B $49.72 779
2020 Q4 394 M $19.7 B -$506 M $49.99 813
2020 Q3 407 M $22.4 B -$916 M $54.80 743
2020 Q2 428 M $22.7 B -$725 M $52.89 696
2020 Q1 442 M $19.8 B -$45.8 M $44.66 617
2019 Q4 447 M $22.3 B -$379 M $49.86 653
2019 Q3 458 M $20.4 B +$180 M $44.57 573
2019 Q2 460 M $19 B -$378 M $41.28 571
2019 Q1 477 M $19.3 B +$552 M $40.43 582
2018 Q4 465 M $17.7 B +$1.1 B $37.98 576
2018 Q3 437 M $17.3 B +$1.31 B $39.57 566
2018 Q2 407 M $14.3 B +$479 M $35.11 558
2018 Q1 397 M $13.9 B +$590 M $34.97 549
2017 Q4 385 M $13.4 B +$412 M $34.70 531
2017 Q3 375 M $12.7 B +$888 M $33.88 490
2017 Q2 360 M $12.3 B +$182 M $34.09 528
2017 Q1 355 M $11.1 B +$1.56 B $31.14 505
2016 Q4 316 M $8.63 B -$109 M $27.32 489
2016 Q3 329 M $10.8 B +$1.67 B $32.86 481
2016 Q2 281 M $8.48 B +$879 M $30.19 426
2016 Q1 254 M $7.15 B +$1.03 B $28.16 406
2015 Q4 221 M $7.51 B +$638 M $33.95 413
2015 Q3 203 M $6.47 B +$3.51 B $31.82 398
2015 Q2 98.1 M $6.19 B +$670 M $63.71 400
2015 Q1 89.8 M $6.14 B +$314 M $68.43 413
2014 Q4 88.8 M $6.19 B +$1.08 B $70.38 456
2014 Q3 76 M $5.36 B -$505 M $71.44 466
2014 Q2 96 M $7.07 B -$1.04 B $74.31 478
2014 Q1 115 M $7.38 B -$441 M $64.88 415